Advertisement Pharmaceutical Business review - Page 484 of 5254 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
December 15, 2025

Sobi buys Arthrosi to expand gout treatment pipeline

Swedish Orphan Biovitrum (Sobi) has signed an agreement for the acquisition of US-based biotechnology company Arthrosi Therapeutics, a move that will expand Sobi’s presence in the gout treatment market.

Continue
Sobi will finance the upfront payment primarily via debt, utilising existing credit facilities and a new credit facility. Credit: © Swedish Orphan Biovitrum AB.
December 15, 2025

FDA approves Acadia’s Daybue Stix for Rett syndrome

Daybue Stix’s efficacy and safety are supported by the outcomes from the LAVENDER study. Credit: Acadia Pharmaceuticals Inc./Business Wire.
December 12, 2025

Zealand Pharma and OTR to develop metabolic disease therapeutics

Zealand Pharma will take on the responsibility for clinical development, regulatory submissions and global commercialisation. Credit: T. Schneider/Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Formycon and Zydus sign exclusive agreement for FYB206 supply
  2. Health Canada approves Biogen’s Zurzuvae for PPD treatment
  3. EC approves Roche’s Gazyva to treat active lupus nephritis
  4. Inductive Bio gains $21m ARPA-H funds for drug prediction models
  5. Viatris signs agreements with Biocon on $815m stake sale

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography